Harmony Biosciences Prices Upsized IPO At $24/Shr, Above The Estimated Range

Harmony Biosciences Holdings, Inc. announced the pricing of its upsized initial public offering of 5.35 million common shares at $24.00 per share, above the estimated range. The offering is expected to close on August 21, 2020.

The company has originally filed to sell 4.65 million shares at a range of $20.00 and $23.00 per share.

The company shares are expected to begin trading on Nasdaq Global Market under the ticker symbol "HRMY" on August 19, 2020. The company expects offering gross proceeds, before expenses, to be $128.4 million.

In addition, Harmony has granted the underwriters a 30-day option to purchase up to an additional 802,325 shares of common stock at the initial public offering price, less underwriting discounts and commissions.

Goldman Sachs & Co. LLC, Jefferies and Piper Sandler are acting as joint book-running managers for the offering.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Asweets Global Inc. is recalling about 2,000 units of Wonder & Wise Activity Tables for potential risk of choking hazard to young children, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the screws of the tables can become loose and/or detach from the xylophone component of the activity tables to pose a choking hazard to young children. Chinese e-commerce giant Alibaba Group Holdings Ltd. (BABA) reported Thursday a net loss for the fourth quarter that sharply widened from last year, despite 9 percent growth in revenues, hurt by a decreases in the market prices of our equity investments in publicly-traded companies. Omni-channel fashion retailer Macy's, Inc. (M) reported Thursday a first-quarter net income of $286 million or $0.98 per share, sharply higher than $103 million or $0.32 per share in the prior-year quarter. Excluding items, adjusted net income for the quarter was $315 million or $1.08 per share, compared...
Follow RTT